Brief: Amicus Therapeutics Reports Q3 Loss Per Share Of $0.12

Amicus Therapeutics

07/11/2022 12:24

Nov 7 (Reuters) - Amicus Therapeutics Inc  FOLD.O :
    * AMICUS THERAPEUTICS ANNOUNCES THIRD QUARTER 2022 FINANCIAL
RESULTS AND CORPORATE UPDATES
    * AMICUS THERAPEUTICS INC- UPDATING FULL-YEAR 2022 NON-GAAP
OPERATING EXPENSE GUIDANCE FROM $470M-$485M TO $430M-$440M
    * AMICUS THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.12

Source text for Eikon:  ID:nGNX9KnL9Y 
Further company coverage:  FOLD.O 
 ((Reuters.Briefs@thomsonreuters.com;))